MagnetOs™ Granules vs. Autograft in Instrumented Posterolateral Spinal Fusion

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 4, 2018

Primary Completion Date

October 30, 2023

Study Completion Date

October 7, 2024

Conditions
Spinal Fusion
Interventions
PROCEDURE

Instrumented posterolateral spinal fusion

Instrumented posterolateral spinal fusion, with or without an additional interbody device

DEVICE

MagnetOs™ Granules

8-10cc of MagnetOs™ Granules per spinal level at the randomized allocation side of the spine (left or right)

PROCEDURE

Autologous bone graft

8-10cc autologous bone graft per spinal level at the control side of the spine (left or right). This can be a combination of local bone and iliac crest bone, but at least 50% of the volume has to be iliac crest bone graft.

Trial Locations (5)

Unknown

Onze Lieve Vrouwe Gasthuis, Amsterdam

Rijnstate Hospital, Arnhem

Amphia Hospital, Breda

St. Antonius Hospital, Nieuwegein

University Medical Center Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Kuros BioSciences B.V.

INDUSTRY

lead

M.C. Kruyt, MD, PhD

OTHER